Discover 3,605 paid clinical trials in Costa Mesa, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,605
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Location: Orange CA, Bakersfield CA, Chandler AZ, Queen Creek AZ,
Sponsor: UroGen Pharma Ltd.
Sex: All
Age: 18+
Code: NCT06774131
Phase 3, Recruiting
Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
for
Lung Cancer, Driver Mutation
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18 - 70+
Code: NCT07062172
Recruiting
An Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705
for
Methylmalonic Acidemia
Location: Los Angeles CA, San Diego CA, Palo Alto CA, Edmonton,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 1+
Code: NCT05295433
Phase 1, Phase 2, Recruiting
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
for
Epstein-Barr Virus Infections,
Location: Los Angeles CA, San Francisco CA, St Louis MO,
Sponsor: New York Medical College
Sex: All
Age: 0 - 70+
Code: NCT03266653
Phase 2, Recruiting
Freedom-1 Study for Chronic Knee Pain
for
Osteoarthritic Knee Pain
Location: Placentia CA, Las Vegas NV, Denver CO, San Antonio TX,
Sponsor: Curonix LLC
Sex: All
Age: 18+
Code: NCT03877653
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers
for
Diabetic Foot Ulcer
Location: Los Angeles CA, Sylmar CA, Fresno CA, Phoenix AZ,
Sponsor: Origin Inc.
Sex: All
Age: 22 - 70+
Code: NCT03078933
Recruiting
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Orange CA, Laguna Hills CA, San Diego CA, Palo Alto CA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06943872
Phase 3, Recruiting
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial
for
Coronary Artery Disease
Location: Long Beach CA, Dallas TX, Houston TX, Birmingham AL,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT05618353
Recruiting
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
for
Psychotic Disorders, Alzheimer Disease
Location: Anaheim CA, Walnut Creek CA, Bellevue WA,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 55+
Code: NCT06540833
Phase 2, Recruiting
Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)
for
Gastroesophageal Adenocarcinoma
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18+
Code: NCT05733689
Phase 1, Recruiting
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Orange CA, Los Angeles CA, Boise ID, Austin TX,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT07154706
Phase 3, Recruiting
ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu
for
Solid Tumor, Adult, Malignant Solid Tumor,
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18+
Code: NCT06824363
Early Phase 1, Recruiting
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Location: Los Angeles CA, Stanford CA, San Francisco CA,
Sponsor: Tyra Biosciences, Inc
Sex: All
Age: 18+
Code: NCT06915753
Phase 1, Recruiting
Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent
for
Acute Myeloid Leukemia
Location: Orange CA, Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 18+
Code: NCT07304011
Phase 2, Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: Orange CA, Stanford CA, Sacramento CA, Aurora CO,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06128551
Phase 1, Phase 2, Recruiting
Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Los Angeles CA, San Francisco CA, Madison WI,
Sponsor: Syntrix Biosystems, Inc.
Sex: Male
Age: 18+
Code: NCT06228053
Phase 2, Recruiting
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
for
Solid Tumor, Adult
Location: Los Angeles CA
Sponsor: BioInvent International AB
Sex: All
Age: 18+
Code: NCT04219254
Phase 1, Phase 2, Recruiting
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)